This is the age you should treat children for peanut allergies, researchers say
Research out of the University of British Columbia is giving more insight into a treatment designed to help young children overcome peanut allergies.
In 2019, researchers demonstrated that a treatment called oral immunotherapy was successful in treating peanut allergies in preschool-aged children.
They now say the earlier the treatment is given, the better the outcome will be.
"This treatment is affordable, very safe and highly effective, particularly if we can get the treatment going before the infant is 12 months old," says the study's senior author Dr. Edmond Chan in a news release.
The study, published in the Journal of Allergy and Clinical Immunology: In Practice, focused on infants under 12 months old and revealed oral immunotherapy is safer and more effective for this age group than it is for toddlers and older pre-schoolers.
According to Chan, oral immunotherapy is "a treatment protocol in which a patient consumes small amounts of the allergenic food — in this case, peanut flour — with the dose gradually increased to a determined maximum amount."
The goal is to desensitize the child until they're able to consume a full serving of peanut protein without it triggering a dangerous reaction.
The research suggests that children must continue to eat peanut products on a regular basis long-term, in order to sustain their immunity.
Throughout the study, a group of children visited a pediatric allergist every two weeks to receive their peanut dose. Parents were also told to provide the same daily dose at home between clinic visits. After eight to 11 visits, researchers found the children had built up to a "maintenance dose" of 300 milligrams of peanut protein, which is the equivalent of about 1.3 grams of peanuts.
They found that 42 infants completed the build-up period, plus one year of maintenance dosing.
"At the end of it, none of them had more than a mild reaction to a 4,000-milligram dose of peanut protein, compared to 7.7 per cent of the children aged one to five who completed the protocol," the study says.
Seven infants dropped out of the study, with four experiencing reactions beyond mild. Researchers say none of the infants required epinephrine injections as a result.
The study also found during initial testing that only 33.9 per cent of infants had a reaction beyond mild, compared to 53.7 per cent of children aged one through five.
"Despite infants showing the best safety, we were still very satisfied with the safety of this treatment for older pre-schoolers. The risk of a severe reaction is much lower than it is for school-age kids," says Chan.
"Many of the interventions we use in medicine, such as medications or surgical procedures, carry a small amount of risk that is outweighed by the benefit. If this treatment is performed by well-trained allergists and clinicians then I'm really comfortable with the risk. It's actually very safe."
When it comes to long-term effectiveness, researchers say the treatment worked "equally well" for both age groups.
"After a year of one peanut per day, approximately 80 per cent of the children had developed a tolerance for 4,000 milligrams of peanut protein one sitting," the study says.
That's the equivalent of about 15 peanuts.
Chan suggests that parents introduce foods like peanut butter or peanut flour to children around six months of age, to help prevent peanut allergies when they get older.
The head of allergy and immunology in UBC's department of pediatrics at the BC Children's Hospital Research Institute, Chan has embraced oral immunotherapy in his own clinical practice.
His research will be used to inform future clinical practice guidelines, the study says.
CTVNews.ca Top Stories
What's a Barnacle? It's yellow, sticks and screams if you try to pry it off your car
Barnacles, bright yellow devices used to make sure parking scofflaws pay their tickets, could soon be making their way to cities across Canada.
They were from different countries and barely spoke each other's languages. More than 20 years later, they're still happily in love
He decided to spend Christmas somewhere that wouldn't involve snowstorm disasters. She was spending the holidays with family, travelling for the first time outside of her native country of Venezuela. 23 years later, they're still in love.
Man who set himself on fire outside Trump trial dies of injuries, police say
A man who doused himself in an accelerant and set himself on fire outside the courthouse where former U.S. President Donald Trump is on trial has died, police said.
Young people 'tortured' if stolen vehicle operations fail, Montreal police tell MPs
One day after a Montreal police officer fired gunshots at a suspect in a stolen vehicle, senior officers were telling parliamentarians that organized crime groups are recruiting people as young as 15 in the city to steal cars so that they can be shipped overseas.
Verdun Airbnb listing taken down amid complaints, fines and frustration from neighbours
An Airbnb in Montreal's Verdun borough was the source of much frustration from neighbours who say there were constant parties at the location. It has been taken down from the app, but housing advocates remain upset about short-term rentals.
Fire in Labrador town under control, officials tells residents to stay away
RCMP say the fire that prompted a state of emergency in a Labrador town is now under control.
12 students and teacher killed in Columbine school shooting remembered at 25th anniversary vigil
Thirteen victims of the Columbine High School shooting were remembered during a vigil Friday on the eve of the 25th anniversary of the shooting that was the worst the nation had seen at the time.
Israeli airstrike in southern Gaza city of Rafah kills at least 9 Palestinians, including 6 children
An Israeli airstrike on a house in Gaza's southernmost city killed at least nine people, six of them children, hospital authorities said Saturday, as Israel pursued its nearly seven-month offensive in the besieged Palestinian territory.
Mandisa, Grammy award-winning 'American Idol' alum, dead at 47
Soulful gospel artist Mandisa, a Grammy-winning singer who got her start as a contestant on 'American Idol' in 2006, has died, according to a statement on her verified social media. She was 47.